IP Library Granted Patent US 9,173,926
Granted Patent B2
US 9,173,926 · App. 14/137,141 · Granted Nov 3, 2015

Use of beta-1,3 (4)-endoglucanohydrolase, beta-1,3 (4)-glucan, diatomaceous earth, mineral clay and glucomannan to augment immune function

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,173,926
App. No.
14/137,141
Granted
Nov 3, 2015
Kind
B2
Abstract

A method for the augmentation of immune function is described. The invention comprises a combination of β-1,3 (4)-endoglucanohydrolase, β-1,3 (4)-glucan, diatomaceous earth, mineral clay and glucomannan, which is fed to or consumed by mammalian or avian species in amounts sufficient to augment immune function. The invention described may be admixed with feeds or foods, incorporated into pelleted feeds or foods or administered orally to mammalian and avian species.

Claims (20)

1. A feed composition, comprising:

a feed; and

a composition comprising silica, a mineral clay, β-glucans, β-1,3 (4)-endoglucanohydrolase, and mannans.

2. The feed composition of claim 1 where the feed is a feed for an animal selected from mammalian and avian species.

3. The feed composition of claim 1 where the silica is provided by diatomaceous earth.

4. The feed composition of claim 1 where the mannans comprise glucomannan.

5. The feed composition of claim 4 where the β-glucans and glucomannan are derived from gram positive yeast cell walls.

6. The feed composition of claim 1 where the mineral clay comprises montmorillonite, bentonite, aluminosilicate, or zeolite clays, or mixtures thereof.

7. The feed composition of claim 1 consisting essentially of the feed and the composition, wherein the composition consists essentially of silica, mineral clay, β-glucans, β-1,3 (4)-endoglucanohydrolase, and mannans.

8. The feed composition of claim 1 where the composition comprising silica, mineral clay, β-glucans, β-1,3 (4)-endoglucanohydrolase, and mannans comprises from about 15% to about 40% silica, from about 50% to about81% mineral clay, from about 1.0% to about 5.0% β-glucans, from about 0.05% to about 3.0% β-1,3 (4)-endoglucanohydrolase, and from about 1% to about 8% mannans.

9. The feed composition of claim 1 where the composition comprising silica, mineral clay, β-glucans, β-1,3 (4)-endoglucanohydrolase, and mannans comprises from about 20% to about 30% silica, from about 60% to about 75% mineral clay, from about 1.0% to about 3.5% β-glucans, from about 0.1% to about 3.0% β-1,3(4)-endoglucanohydrolase, and from about 1.0% to about 6.0% mannans.

10. The feed composition of claim 1 where the feed composition comprises from about 0.0125 wt % to about 5 wt % of the composition comprising silica, mineral clay, β-glucans, β-1,3 (4)-endoglucanohydrolase, and mannans by weight of the feed.

11. The feed composition of claim 1 where the feed composition comprises from about 0.0125 wt % to about 2 wt % of the composition comprising silica, mineral clay, β-glucans, β-1,3 (4)-endoglucanohydrolase, and mannans by weight of the feed.

12. The feed composition of claim 1 where the feed composition comprises from about 0.0625 wt % to about 2 wt % of the composition comprising silica, mineral clay, β-glucans, β-1,3 (4)-endoglucanohydrolase, and mannans by weight of the feed.

13. The feed composition of claim 1 where the feed composition comprises from about 0.125 wt % to about 0.5 wt % of the composition comprising silica, mineral clay, β-glucans, β-1,3 (4)-endoglucanohydrolase, and mannans by weight of the feed.

14. The feed composition of claim 1 where the feed composition comprises from about 0.1 kg to about 5 kg of the composition comprising silica, mineral clay, β-glucans, β-1,3 (4)-endoglucanohydrolase, and mannans per ton of the feed.

15. The feed composition of claim 1 where the feed composition comprises from about 1 kg to about 2 kg of the composition comprising silica, mineral clay, β-glucans, β-1,3 (4)-endoglucanohydrolase, and mannans per ton of the feed.

16. The feed composition of claim 1 where the feed is selected for ruminant animals.

17. The feed composition of claim 1 where the feed is selected for dairy cattle, beef cattle, or sheep.

18. A method, comprising administering the feed composition of claim 1 to an animal selected from mammalian and avian species.

Assignments (5)
RELEASE OF SECURITY INTEREST IN PATENTS AT REEL 42877, FRAME 0441 Recorded Jul 17, 2024
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: PHIBRO ANIMAL HEALTH CORPORATION; OMNIGEN RESEARCH, LLC; PRINCE AGRI PRODUCTS, INC.
Reel/Frame 068404/0550 →
RELEASE OF SECURITY INTEREST Recorded Jun 30, 2017
From: BANK OF AMERICA, N.A.
To: PHIBRO ANIMAL HEALTH CORPORATION; PRINCE AGRI PRODUCTS, INC.; OMNIGEN RESEARCH, LLC
Reel/Frame 042877/0343 →
SECURITY INTEREST Recorded Jun 30, 2017
From: PHIBRO ANIMAL HEALTH CORPORATION; OMNIGEN RESEARCH, LLC; PRINCE AGRI PRODUCTS, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 042877/0441 →
PATENT SECURITY AGREEMENT SUPPLEMENT Recorded Jan 14, 2016
From: PHIBRO ANIMAL HEALTH CORPORATION; PRINCE AGRI PRODUCTS, INC.; OMNIGEN RESEARCH, LLC
To: BANK OF AMERICA, N.A.
Reel/Frame 037521/0291 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 8, 2014
From: PUNTENNEY, STEVEN B.; FORSBERG, NEIL E.
To: OMNIGEN RESEARCH, LLC
Reel/Frame 032629/0884 →